Editorial: Mechanism and pharmacodynamic material basis of neurodegenerative disease therapies

Affiliations

Erxi Wu: Department of Neurosurgery and Neuroscience Institute, Baylor Scott and White Health, Temple, TX, United States
Erxi Wu: Department of Medical Education, Texas A&M University School of Medicine, Temple, TX, United States
Erxi Wu: Department of Pharmaceutical Science, Texas A&M University School of Pharmacy, College Station, TX, United States
Erxi Wu: Department of Oncology, Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin, Austin, TX, United States
Ronghu Ke: Department of Neurosurgery and Neuroscience Institute, Baylor Scott and White Health, Temple, TX, United States
Dan Qi: Department of Neurosurgery and Neuroscience Institute, Baylor Scott and White Health, Temple, TX, United States
Jason H. Huang: Department of Neurosurgery and Neuroscience Institute, Baylor Scott and White Health, Temple, TX, United States
Jason H. Huang: Department of Medical Education, Texas A&M University School of Medicine, Temple, TX, United States
Jason H. Huang: Department of Neurosurgery, Baylor College of Medicine, Temple, TX, United States

Abstract

No abstracts available.

ISSN: 1662-4548 (Print); 1662-453X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
Website: http://www.frontiersin.org/neuroscience